When facing a cancer diagnosis, treatment decisions aren’t always straightforward. While some people require immediate intervention, others may benefit from a more measured approach. 4PBA is an option that can be integrated into different stages of cancer care—whether for active surveillance, proactive blood cancer management, or active solid tumor treatment.

• Active Surveillance for Low- or Intermediate-Grade Solid Tumors – For certain slow-growing cancers, immediate aggressive treatment may not be necessary. 4PBA can be used as part of an active surveillance plan, potentially helping to maintain stability while keeping treatment options open.
  
• Proactive Treatment for Blood Cancers – Conditions like chronic leukemias, myelodysplastic syndromes (MDS), and low-grade lymphomas require close monitoring. 4PBA has shown promise in stabilizing blood counts, slowing disease progression, and improving overall quality of life.
  
• Active Treatment for Solid Tumors – In cases where intervention is needed, 4PBA may complement surgery, chemotherapy, or radiation by targeting the underlying mechanisms of tumor growth, potentially enhancing treatment outcomes.